Kenya vs Niger: Population requiring preventive chemotherapy for schistosomiasis
Kenya
4.77 million
in 2024
Niger
5.10 million
in 2024
Kenya rank
18th
Niger rank
16th
Population requiring preventive chemotherapy for schistosomiasis over time
- Kenya
- Niger
How they compare
Niger currently reports 5.10 million against 4.77 million in Kenya, a difference of 332,560.
That makes Niger's figure about 1.1 times Kenya's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Kenya ahead.
Kenya ranks 18th and Niger ranks 16th of 52 countries.
Across the 2 decades both report, Kenya averaged higher in 1 and Niger in 1.
Head to head by decade
| Decade | Kenya | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.35 million | 5.02 million | 1.33 million | Kenya |
| 2020s | 4.24 million | 8.69 million | 4.45 million | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Kenya or Niger?
- Niger, at 5.10 million against 4.77 million in Kenya as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Kenya and Niger?
- 332,560, with Niger ahead.
- How many years of comparable data are there for Kenya and Niger?
- 15 years are reported by both, from 2010 to 2024.
- How do Kenya and Niger rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Kenya ranks 18th and Niger ranks 16th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.